PLD6 and colorectal carcinoma: PLD6-WT overexpression but not the PLD6-H156N mutant restored the capacities suppressed by metformin (Supplementary Fig. 3b, c), indicating that PLD6-enhanced mitochondrial metabolism plays a significant oncogenic role in CRC cells.